病例报告：2019年冠状病毒病信使核糖核酸疫苗接种后发生急性暴发性心肌炎和心源性休克并需要体外心肺复苏
Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation.
作者信息
Lim Yongwhan, Kim Min Chul, Kim Kye Hun, Jeong In-Seok, Cho Yong Soo, Choi Yoo Duk, Lee Jong Eun
机构信息
Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital, Gwangju, South Korea.
Department of Cardiothoracic Surgery, Chonnam National University Medical School/Hospital, Gwangju, South Korea.
出版信息
Front Cardiovasc Med. 2021 Oct 29;8:758996. doi: 10.3389/fcvm.2021.758996. eCollection 2021.
Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually associated with a benign clinical course without intensive care or any sequelae of fulminant myocarditis. Here, we report a case of acute fulminant myocarditis and cardiogenic shock after the mRNA COVID-19 vaccination, requiring extracorporeal cardiopulmonary resuscitation. Clinicians should keep in mind the possibility of progression to fulminant myocarditis in patients who presented with suggestive symptoms or signs of myocarditis after the COVID-19 vaccination.
最近，新型冠状病毒肺炎（COVID-19）信使核糖核酸（mRNA）疫苗接种后发生的心肌炎已成为全球一个重要的社会问题。根据目前的报告，与mRNA COVID-19疫苗接种相关的心肌炎很罕见，通常伴有良性临床过程，无需重症监护，也不会出现暴发性心肌炎的任何后遗症。在此，我们报告1例mRNA COVID-19疫苗接种后发生急性暴发性心肌炎和心源性休克的病例，需要进行体外心肺复苏。临床医生应牢记，接种COVID-19疫苗后出现提示心肌炎的症状或体征的患者有可能进展为暴发性心肌炎。
Zotero 插件